Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

TFA Therapeutics, Inc.

CIK 1885680Updated Nov 16, 2026

Name history
Cordyceps Sunshine Biotech Holdings Co., Ltd. · through Jun 25, 2026

RAJAF price & chart

Provider market data

Loading TradingView…

OTC:RAJAF on TradingView ↗

TradingView · Data may be delayed

In the news

No coverage from other publishers is available.

Recent filings

  1. 6-K filing

    6-K · 2026-09-02 · 0001213900-26-096447

  2. 6-K filing

    6-K · 2026-07-27 · 0001213900-26-081806

  3. 6-K filing

    6-K · 2026-06-25 · 0001213900-26-071711

  4. 20-F filing

    20-F · 2026-05-15 · 0001213900-26-057774

  5. NT 20-F filing

    NT 20-F · 2026-04-30 · 0001213900-26-050286

Show 5 more recent filings
  1. 6-K filing

    6-K · 2025-11-26 · 0001213900-25-115017

  2. 20-F/A filing

    20-F/A · 2025-09-23 · 0001213900-25-090714

  3. 20-F filing

    20-F · 2025-06-13 · 0001213900-25-054317

  4. NT 20-F filing

    NT 20-F · 2025-04-30 · 0001213900-25-037684

  5. 6-K filing

    6-K · 2024-12-06 · 0001213900-24-106507

Financials

FY 2025 · USD
Revenue1,245,348USD · FY 2025
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

Net income-154,822USD · FY 2025
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

Operating income-141,128USD · FY 2025
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

Diluted EPS0USD per share · FY 2025
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2023Q3 2022FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD1,797,722
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—4,657,511
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

4,623,704
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

3,351,782
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

2,104,853
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Property, Plant and Equipment, NetUSD1,545,203
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—3,632,901
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

3,909,599
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

2,814,766
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

1,425,135
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD16,911
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—3,199
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

37,284
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

23,104
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

16,100
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD———305
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

—149,510
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Inventory, NetUSD4,308
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—674,196
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

——313,530
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Assets, CurrentUSD52,135
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—997,742
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

601,602
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

327,175
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

501,552
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD——13,097
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

99,328
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

195,775
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

—
Other Assets, NoncurrentUSD——13,771
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

13,175
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

14,066
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

—
LIABILITIES AND EQUITY
LiabilitiesUSD1,980,661
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—5,192,062
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

4,999,247
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

3,503,578
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

3,056,187
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD11,112
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—11,112
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

11,112
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

11,112
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

11,112
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Additional Paid in CapitalUSD221,288
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—221,288
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

221,288
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

221,288
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

221,288
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-477,490
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—-854,046
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

-699,224
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

-472,966
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

-1,224,575
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD62,151
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—87,095
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

91,281
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

88,770
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

40,841
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD-182,939
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

117,086
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2022-09-30

-534,551
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

-375,543
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

-151,796
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

-951,334
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Liabilities and EquityUSD1,797,722
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—4,657,511
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

4,623,704
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

3,351,782
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

2,104,853
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD1,465,332
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—5,192,062
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

4,986,645
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

2,966,143
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

2,935,130
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Operating Lease, Liability, CurrentUSD99,055
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

—13,173
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

87,016
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

90,091
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

57,109
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Accounts Payable, CurrentUSD——365,140
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

276,125
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

185,434
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

751,135
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD101,329
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

——12,602
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

106,356
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

121,057
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD——85,074
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

32,410
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

26,889
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

62,754
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Long-term Debt, Current MaturitiesUSD99,055
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

————57,109
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Long-term Debt, Excluding Current MaturitiesUSD————431,079
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

—

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2023Q4 2022Q3 2023Q3 2022FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————56,757
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

168,899
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD———————-185,797
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Increase (Decrease) in InventoriesUSD————358,549
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

—192,634
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-48,833
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Increase (Decrease) in Accounts PayableUSD——————182,849
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-122,450
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Deferred Income Tax Expense (Benefit)USD——————-42,221
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

—
Net Cash Provided by (Used in) Operating ActivitiesUSD————-35,845
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

312,006
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

359,724
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-321,378
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD—————-305,637
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

-319,820
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-475
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD—————349,237
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

319,487
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

475
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————-32,208
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

245,787
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD————-34,085
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

14,180
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

7,004
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-83,584
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——16,974
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2023-09-30

19,336
Source

6-K · 2023-11-13 · 0001213900-23-085555

As of 2022-09-30

3,199
Source

20-F · 2026-05-15 · 0001213900-26-057774

As of 2025-12-31

37,284
Source

20-F · 2025-06-13 · 0001213900-25-054317

As of 2024-12-31

23,104
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

As of 2023-12-31

16,100
Source

20-F · 2023-05-15 · 0001213900-23-039368

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD————2,185
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

150
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

——
Income Taxes Paid, NetUSD———————792
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD————1,760
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

7,811
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

-692
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-7,518
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Additional Financial Items
AmortizationUSD————74,017
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

16,793
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

——
Amortization of Debt Issuance CostsUSD——————86,216
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

—
DepreciationUSD————135,243
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

407,265
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

56,757
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

24,760
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD——————865,085
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Gain (Loss) on Disposition of AssetsUSD—————4,328
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

——
Gain (Loss) on Disposition of Property Plant EquipmentUSD——————2,437,980
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
General and Administrative ExpenseUSD——————538,554
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

572,589
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Goodwill and Intangible Asset ImpairmentUSD———————1,177
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD————-154,822
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-226,258
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

169,285
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD——————582,324
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Income Tax Expense (Benefit)USD—————34,957
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

21,530
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

792
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Inventory Write-downUSD———————84,709
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD————-154,822
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-226,258
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

751,609
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-720,093
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD————-13,694
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-7,388
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

37,018
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-76,599
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Operating ExpensesUSD————901,869
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

717,673
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

538,554
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

576,030
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD————91,310
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

90,609
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

81,203
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Other Nonoperating Income (Expense)USD————5,485
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

5,339
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

-37,018
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-4,855
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Realized Investment Gains (Losses)USD——————865,085
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

—

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2023Q4 2022FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——1,245,348
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

1,253,484
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

882,533
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

448,785
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Cost of Goods and Services Sold———
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

—
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

—
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——-141,128
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-183,913
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

227,833
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-642,702
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——5,485
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

5,339
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

-37,018
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-4,855
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——-154,822
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-191,301
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

190,815
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Income Tax Expense (Benefit)USD———34,957
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

21,530
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

792
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-154,822
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-226,258
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

751,609
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-720,093
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——0
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

0
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

0.01
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-0.01
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——0
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

0
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

0.01
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-0.01
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——111,120,000
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

111,120,000
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

111,120,000
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

104,417,534
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——111,120,000
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

111,120,000
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

111,120,000
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

104,417,534
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Additional Financial Items
Current Income Tax Expense (Benefit)USD———34,957
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

21,530
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Depreciation, Depletion and Amortization, NonproductionUSD—————168,899
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD————538,554
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

572,589
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Gross ProfitUSD——760,741
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

533,760
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

766,387
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-66,672
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD——-154,822
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-226,258
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

169,285
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Income (Loss) from Continuing Operations, Per Basic ShareUSD per share——0
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

0
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

0
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share——0
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

0
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

0
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD————582,324
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Interest ExpenseUSD————26,535
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

71,772
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Interest Income (Expense), Nonoperating, NetUSD——-19,179
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-17,055
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

-39,770
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Interest Income, OtherUSD————7
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

28
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Labor and Related ExpenseUSD————109,295
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

110,938
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——-13,694
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

-7,388
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

37,018
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

-76,599
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Operating ExpensesUSD——901,869
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

717,673
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

538,554
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

576,030
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——91,310
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

90,609
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

81,203
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Other ExpensesUSD—————35,690
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Other General and Administrative ExpenseUSD——901,869
Source

20-F · 2026-05-15 · 0001213900-26-057774

2025-01-01 to 2025-12-31

717,673
Source

20-F · 2025-06-13 · 0001213900-25-054317

2024-01-01 to 2024-12-31

193,569
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

—
Other IncomeUSD————2,752
Source

20-F/A · 2025-09-23 · 0001213900-25-090714

2023-01-01 to 2023-12-31

—
Realized Investment Gains (Losses)USD————865,085
Source

20-F · 2024-07-05 · 0001213900-24-059406

2023-01-01 to 2023-12-31

—
Research and Development ExpenseUSD—————118,444
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Selling ExpenseUSD—————3,441
Source

20-F · 2023-05-15 · 0001213900-23-039368

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ea030418701ex99-1.htm · 6-K · 2026-09-02

Exhibit 99.1 TFA THERAPEUTICS, INC. (formerly known as Cordyceps Sunshine Biotech Holdings Co., Ltd.) OTCQB: RAJAF PRIVATE PLACEMENT ORDINARY SHARE SUBSCRIPTION AGREEMENT CONFIDENTIAL - INVITATION ONLY; NO PUBLIC DISTRIBUTION OR U.S. DIRECTED SELLING EFFORTS The Shares have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or any state securities law and are offered solely in reliance upon an applicable exemption. Neither the U.S. Securities and Ex…

6-K · 2026-09-02 · 0001213900-26-096447

Read attachment ↗
ea029590801ex99-1.htm · 6-K · 2026-06-25

Exhibit 99.1 AntcinA(樟芝酸A)合作發展協議 Cooperation and Development Agreement for the Antcin A Platform 甲方 / Party A 天寵生物研究股份有限公司 乙方 / Party B 英屬開曼群島商天草控股股份有限公司 前言 / Recitals 緣甲方係依據中華民國法律登記設立的公司,乙方係依據英屬開曼群島法律登記設立的公司,甲方同意將其所有 Antcin A(樟芝酸A)平台(以下稱「Antcin A平台」)相關之全球商業化權利、授權權利及資本市場發展權利依據本協議的約定無償授權乙方。本協議目的並非移轉Antcin A平台資產法律所有權,而係建立甲、乙雙方合作發展關係。 第一條 定義 / Definitions Antcin A平台資產包括以樟芝酸A為核心之所有技術、資料、研究成果、法規成果、智慧財產、相關商業化成果及相關衍生權利,包括但不限於全球商業化權利、授權權利及資本市場發展權利;Antcin A平台產品包括但不限於TFA-01及未來衍生產品、改良分子、新適應症、人體用藥…

6-K · 2026-06-25 · 0001213900-26-071711

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.